Netanyahu reveals he underwent treatment for prostate cancer

Jerusalem – Prime Minister Benjamin Netanyahu has disclosed for the first time that he received treatment for a malignant prostate tumor, a revelation made public through his social media channels and coinciding with the release of his annual medical assessment. The surgery, initially reported as being for benign prostate enlargement in December 2024, was in fact to address a cancerous growth.

According to the released report, the 76-year-old premier is in good health, with all his blood analyses and physical fitness tests returning normal results. His cardiac condition remains satisfactory, with no complications reported since the implantation of a pacemaker in July 2023. He also underwent surgery for a hernia in March 2024.

Netanyahu stated that he deliberately delayed the publication of his medical report by two months. He cited a desire to avoid providing the "terrorist regime in Iran" with further ammunition for "lying propaganda" against the State of Israel. This disclosure comes amidst a period where rumors about the Prime Minister's health have circulated, particularly during intense conflict periods earlier this year.

From our perspective at La Presse, this transparency, albeit delayed, is crucial. While Western media might focus on the political timing, for us in Tunisia and the wider Arab world, understanding the health status of regional leaders is paramount. Netanyahu's decision to link the delay to Iranian propaganda underscores the ongoing regional tensions and the information warfare that characterizes our geopolitical landscape. The focus remains on stability and the leader's capacity to govern, especially during challenging times.

“

the terrorist regime in Iran